ArticleBritish journal of cancer2008

Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics.

R Stoehr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.